News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
Presentation TCT 2022 TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg ) Presenter: Yoshinobu Onuma September 17, 2022
News Conference News TCT 2022 PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope Todd Neale September 17, 2022
Presentation TCT 2022 TCT 54: Bifurcation Left Main Coronary Stenting with or without intracoronary imaging: Outcomes From the European Bifurcation Club Left Main trial Presenter: Annette Maznyczka September 17, 2022
Presentation TCT 2022 Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation) Presenter: Naomi Fisher September 17, 2022
Presentation TCT 2022 Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation) Presenter: David Kandzari September 17, 2022
Presentation TCT 2022 TCT 22: Clopidogrel versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients with Acute Coronary syndrome: Subgroup Analysis of the HOST-EXAM trial Presenter: Jeehoon Kang September 17, 2022
Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022
Presentation TCT 2022 TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials Presenter: Toshiki Kuno September 17, 2022
Presentation TCT 2022 TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial Presenter: Roland Schmieder September 17, 2022
Presentation TCT 2022 TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial Presenter: Alexander Fanaroff September 17, 2022
Presentation TCT 2022 First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation Presenter: David Adams September 17, 2022
Presentation TCT 2022 TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial Presenter: Zardasht Oqab September 17, 2022
Presentation TCT 2022 TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial Presenter: Kevin Bainey September 17, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News TCT 2022 TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US Caitlin E. Cox September 16, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On Caitlin E. Cox November 09, 2021